Development of a Practical Synthesis of Toll-like Receptor Agonist PF-4171455: 4-Amino-1-benzyl-6-trifluoromethyl-1,3-dihydroimidazo [4,5-c] pyridin-2-one

The development and implementation of a scalable process for the manufacture of the Toll-like receptor (TLR7) agonist PF-4171455 (1) is described. Initial routes used to synthesise 1 in milligram quantities were unsuitable for large-scale synthesis to provide bulk material. As part of the transfer b...

Full description

Saved in:
Bibliographic Details
Published inOrganic process research & development Vol. 15; no. 4; pp. 788 - 796
Main Authors Adam, Fiona M, Bish, Gerwyn, Calo, Frederick, Carr, Christopher L, Castro, Nieves, Hay, Duncan, Hodgson, Paul B, Jones, Peter, Knight, Craig J, Paradowski, Michael, Parsons, Gemma C, Proctor, Katie J. W, Pryde, David C, Rota, Filippo, Smith, Mya C, Smith, Nicholas, Tran, Thien-Duc, Hitchin, James, Dixon, Rachel
Format Journal Article
LanguageEnglish
Published American Chemical Society 15.07.2011
Online AccessGet full text

Cover

Loading…
More Information
Summary:The development and implementation of a scalable process for the manufacture of the Toll-like receptor (TLR7) agonist PF-4171455 (1) is described. Initial routes used to synthesise 1 in milligram quantities were unsuitable for large-scale synthesis to provide bulk material. As part of the transfer between Medicinal Chemistry and Research-API, collaboration provided a fit for purpose route for the kilo-scale synthesis of 1. Key aspects of the synthesis included (i) a safe and practical synthesis of a key nitropyridone intermediate 7 over four steps, (ii) a sequential regioselective chlorination to selectively functionalise 7 and (iii) use of a carbamate as a tethered carbonyl group, allowing an efficient regiospecific synthesis of 1.
ISSN:1083-6160
1520-586X
DOI:10.1021/op200021a